Cargando…
Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease
As the number of global deaths attributed to cardiovascular disease continues to rise, viable treatments for cardiovascular events such as myocardial infarction or conditions like peripheral artery disease are critical. Recent studies investigating injectable biomaterials have shown promise in promo...
Autores principales: | Hernandez, Melissa J., Christman, Karen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646282/ https://www.ncbi.nlm.nih.gov/pubmed/29057375 http://dx.doi.org/10.1016/j.jacbts.2016.11.008 |
Ejemplares similares
-
Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury
por: DeFilippis, Andrew P., et al.
Publicado: (2019) -
2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction
por: Chang, Kiyuk, et al.
Publicado: (2021) -
Therapeutic Angiogenesis for Peripheral Artery Disease: Lessons Learned in Translational Science
por: Iyer, Sunil R., et al.
Publicado: (2017) -
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease
por: Franczyk-Skóra, Beata, et al.
Publicado: (2013) -
Macrophage Polarization as a Novel Therapeutic Target for Endovascular Intervention in Peripheral Artery Disease
por: Tan, Richard P., et al.
Publicado: (2021)